Find the latest information on COVID-19, monkeypox, and the flu vaccine
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Myasthenia gravis is a rare, chronic disorder that causes weakness and rapid fatigue of muscles. The muscle weakness develops slowly, first affecting the facial muscles and causing symptoms that include drooping eyelids, double vision, and difficulty talking, chewing, swallowing, or breathing.
The exact cause of myasthenia gravis is not known. But it is known that the antibodies formed by the body's immune system to fight infection instead attack normal muscle tissue. Myasthenia gravis can occur at any age in both women and men. But it is most common in young women who have problems with the thymus gland.
Treatment for myasthenia gravis includes medicine to help reduce and improve muscle weakness. Surgery to remove the thymus gland may be helpful in some cases.
Clinical Trials for Myasthenia Gravis
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
We diagnose and treat myasthenia gravis using advanced techniques and new therapies. Our comprehensive care includes access to clinical trials.
myasthenia gravis myasthenia gravis symptoms myasthenia gravis treatment